Published in Hepatitis Weekly, January 27th, 2003
In addition to blood safety concerns, UDC helps to detect viral hepatitis and human immunodeficiency virus infections. A new report, published in the January 3, 2003, Morbidity and Mortality Weekly Report, presents findings of an investigation conducted during May 1998-June 2002 that identified 1149 seroconversions for hepatitis viruses among people with bleeding disorders who were enrolled voluntarily in UDC.
None of these cases was attributable to blood products...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.